SCHEMBL4664121

SCHEMBL4664121

CN(C)CC1CC(Cc2ccc(Cl)cc2)CCC1(O)CC1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.38
SLC6A3 Q01959 2/20 0.38
OPRM1 P35372 5/20 0.36
OPRL1 P41146 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TRPA1 O75762 2/20 0.35
SLC6A2 P23975 5/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
EPHX1 P07099 1/20 0.34
OPRD1 P41143 3/20 0.34
OPRK1 P41145 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.34
SIGMAR1 Q99720 1/20 0.33
SLC22A1 O15245 2/20 0.32
CHRM2 P08172 1/20 0.32
CHRM1 P11229 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4663522 0.89 TRPA1 (0.44) SLC6A4SLC6A3OPRM1SMN1; SMN2TRPA1
SCHEMBL4663731 0.86 OPRM1 (0.36) SLC6A4SLC6A3OPRM1SMN1; SMN2TRPA1
SCHEMBL4663513 0.83 SLC6A4 (0.36) SLC6A4SLC6A3OPRM1OPRL1SMN1; SMN2
SCHEMBL4664004 0.82 SLC6A4 (0.37) SLC6A4SLC6A3OPRM1OPRL1SMN1; SMN2
SCHEMBL4665379 0.81 OPRK1 (0.42) SLC6A4SLC6A3OPRM1SMN1; SMN2SLC6A2
SCHEMBL4665434 0.81 GMNN (0.39) OPRM1TRPA1OPRD1OPRK1
SCHEMBL4663618 0.81 GMNN (0.39) OPRM1TRPA1OPRD1OPRK1
SCHEMBL4663541 0.81 ALDH1A1 (0.39) OPRM1OPRL1SMN1; SMN2OPRD1OPRK1
SCHEMBL4663381 0.80 SMN1; SMN2 (0.41) SLC6A4SLC6A3OPRM1SMN1; SMN2SLC6A2
SCHEMBL4663652 0.80 SLC6A2 (0.34) SLC6A4OPRM1SMN1; SMN2SLC6A2OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1571140-B1 C-substituted cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2008-11-12 EP claimed
US-7273952-B2 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2007-09-25 US claimed
US-20030232891-A1 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2003-12-18 US claimed
EP-1571140-B1 C-substituted cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2008-11-12 EP disclosed
US-7273952-B2 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2007-09-25 US disclosed
EP-1571140-A1 C-substituted cyclohexylmethylamine derivatives Grünenthal GmbH (DE) 2005-09-07 EP disclosed
US-20030232891-A1 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2003-12-18 US disclosed
EP-1368299-A2 SUBSTITUTED C-CYCLOHEXYLMETHYLAMINE DERIVATIVES Grünenthal GmbH (DE) 2003-12-10 EP disclosed
WO-2002030870-A2 SUBSTITUTED C-CYCLOHEXYLMETHYLAMINE DERIVATIVES Grünenthal GmbH (DE) 2002-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232891-A1 Substituted C-cyclohexylmethylamine derivatives CNR2, CNR1, HNMT SLC6A4 358/4885SLC6A3 995/4885OPRM1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.